Severe combined immunodeficiency with B-lymphocytes (T-B+SCID): report of two cases

J S Lin1, S D Shyur, H Y Lin

  • 1Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan.

Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi [Journal]. Zhonghua Minguo Xiao Er Ke Yi Xue Hui
|February 2, 1999
PubMed

Insights

Early diagnosis of severe combined immunodeficiency (SCID) is critical for infants. This study highlights key indicators and challenges in identifying T-B+SCID, emphasizing the need for timely intervention to improve outcomes.

Area of Science:

  • Pediatric Immunology
  • Clinical Genetics
  • Infectious Diseases

Background:

  • Severe combined immunodeficiency (SCID) is a rare, life-threatening pediatric condition.
  • Early diagnosis and intervention are crucial for infant survival.
  • SCID presents as a failure of both cellular and humoral immunity, with subtypes like T-B+SCID.

Observation:

  • Two male infants presented with severe pulmonary distress and hypoxemia, indicative of T-B+SCID.
  • Family histories revealed early infant deaths from infections, a key diagnostic clue.
  • Clinical manifestations included severe mucocutaneous candidiasis and suspected Pneumocystis carinii pneumonitis (PCP).

Findings:

  • Immunological evaluation showed decreased T-cell and NK cell counts, increased B-cells, and variable immunoglobulin levels (except elevated IgM in one case).
  • These findings are consistent with T-B+SCID, including X-linked SCID and Jak-3-deficient SCID.
  • Grave clinical condition precluded bone marrow transplantation, the only curative treatment.

Implications:

  • This case series underscores the importance of recognizing SCID symptoms in infants with recurrent infections and family history.
  • Prompt diagnostic workup, including immune profiling, is essential for timely management.
  • The limited treatment options and poor prognosis for advanced T-B+SCID highlight the need for improved early detection strategies.